214.625 Legislative findings -- Consent for medical procedures and tests including HIV infection -- Physician's responsibility -- Confidentiality of results -- Exceptions -- Disclosure -- Network
Loading PDF...
Exceptions -- Disclosure -- Network of voluntary HIV testing programs. (1) The General Assembly finds that the use of tests designed to reveal a condition indicative of human immunodeficiency virus (HIV) infection can be a valuable tool
in protecting the public health. The General Assembly finds that despite current
scientific knowledge that zidovudine (AZT) prolongs the lives of acquired
immunodeficiency syndrome victims, and may also be effective when introduced in
the early stages of human immunodeficiency virus infection, many members of the
public are deterred from seeking testing because they misunderstand the nature of
the test or fear that test results will be disclosed without their consent. The General
Assembly finds that the public health will be served by facilitating informed,
voluntary, and confidential use of tests designed to detect human immunodeficiency
virus infection. (2) A person who has signed a general consent form for the performance of medical procedures and tests is not required to also sign or be presented with a specific
consent form relating to medical procedures or tests to determine human
immunodeficiency virus infection, antibodies to human immunodeficiency virus, or
infection with any other causative agent of acquired immunodeficiency syndrome
that will be performed on the person during the time in which the general consent
form is in effect. However, a general consent form shall instruct the patient that, as
part of the medical procedures or tests, the patient may be tested for human
immunodeficiency virus infection, hepatitis, or any other blood-borne infectious
disease if a doctor or advanced practice registered nurse orders the test for
diagnostic purposes. Except as otherwise provided in subsection (5)(c) of this
section, the results of a test or procedure to determine human immunodeficiency
virus infection, antibodies to human immunodeficiency virus, or infection with any
probable causative agent of acquired immunodeficiency syndrome performed under
the authorization of a general consent form shall be used only for diagnostic or
other purposes directly related to medical treatment. (3) In any emergency situation where informed consent of the patient cannot reasonably be obtained before providing health-care services, there is no requirement that a
health-care provider obtain a previous informed consent. (4) The physician or advanced practice registered nurse who orders the test pursuant to subsections (1) and (2) of this section, or the attending physician, shall be
responsible for informing the patient of the results of the test if the test results are
positive for human immunodeficiency virus infection. If the tests are positive, the
physician or advanced practice registered nurse shall also be responsible for either:
(a) Providing information and counseling to the patient concerning his infection or diagnosis and the known medical implications of such status or condition;
or (b) Referring the patient to another appropriate professional or health-care facility for the information and counseling. Page 2 of 5 (5) (a) No person in this state shall perform a test designed to identify the human immunodeficiency virus, or its antigen or antibody, without first obtaining the
informed consent of the person upon whom the test is being performed, except
as specified in subsections (2) and (3) of this section. (b) No test result shall be determined as positive, and no positive test result shall be revealed to any person, without corroborating or confirmatory tests being
conducted. (c) No person who has obtained or has knowledge of a test result pursuant to this section shall disclose or be compelled to disclose the identity of any person
upon whom a test is performed, or the results of the test in a manner which
permits identification of the subject of the test, except to the following
persons:
1. The subject of the test or the subject's legally authorized representative; 2. Any person designated in a legally effective release of the test results
executed prior to or after the test by the subject of the test or the
subject's legally authorized representative; 3. A physician, nurse, or other health-care personnel who has a legitimate
need to know the test result in order to provide for his protection and to
provide for the patient's health and welfare; 4. Health-care providers consulting between themselves or with health-care
facilities to determine diagnosis and treatment; 5. The cabinet, in accordance with rules for reporting and controlling the
spread of disease, as otherwise provided by state law; 6. A health facility or health-care provider which procures, processes,
distributes, or uses:
a. A human body part from a deceased person, with respect to
medical information regarding that person; or b. Semen provided prior to July 13, 1990, for the purpose of artificial
insemination; 7. Health facility staff committees, for the purposes of conducting program
monitoring, program evaluation, or service reviews; 8. Authorized medical or epidemiological researchers who shall not further
disclose any identifying characteristics or information; 9. A parent, foster parent, or legal guardian of a minor; a crime victim; or a
person specified in KRS 438.250; 10. A person allowed access by a court order which is issued in compliance with the following provisions:
a. No court of this state shall issue an order to permit access to a test
for human immunodeficiency virus performed in a medical or
public health setting to any person not authorized by this section or
by KRS 214.420. A court may order an individual to be tested for
human immunodeficiency virus only if the person seeking the test Page 3 of 5 results has demonstrated a compelling need for the test results
which cannot be accommodated by other means. In assessing
compelling need, the court shall weigh the need for testing and
disclosure against the privacy interest of the test subject and the
public interest which may be disserved by disclosure which deters
blood, organ, and semen donation and future human
immunodeficiency virus-related testing or which may lead to
discrimination. This paragraph shall not apply to blood bank donor
records; b. Pleadings pertaining to disclosure of test results shall substitute a
pseudonym for the true name of the subject of the test. The
disclosure to the parties of the subject's true name shall be
communicated confidentially, in documents not filed with the
court; c. Before granting any order, the court shall provide the individual
whose test result is in question with notice and a reasonable
opportunity to participate in the proceedings if he is not already a
party; d. Court proceedings as to disclosure of test results shall be
conducted in camera, unless the subject of the test agrees to a
hearing in open court or unless the court determines that a public
hearing is necessary to the public interest and the proper
administration of justice; and e. Upon the issuance of an order to disclose test results, the court
shall impose appropriate safeguards against unauthorized
disclosure, which shall specify the persons who may have access to
the information, the purposes for which the information shall be
used, and appropriate prohibitions on future disclosure. No person to whom the results of a test have been disclosed shall disclose the
test results to another person except as authorized by this subsection. When
disclosure is made pursuant to this subsection, it shall be accompanied by a
statement in writing which includes the following or substantially similar
language: "This information has been disclosed to you from records whose
confidentiality is protected by state law. State law prohibits you from making
any further disclosure of such information without the specific written consent
of the person to whom such information pertains, or as otherwise permitted by
state law. A general authorization for the release of medical or other
information is NOT sufficient for this purpose." An oral disclosure shall be
accompanied by oral notice and followed by a written notice within ten (10)
days. (6) (a) The Cabinet for Health and Family Services shall establish a network of voluntary human immunodeficiency virus testing programs in every county in
the state. These programs shall be conducted in each public health department
established under the provisions of KRS Chapter 211. Additional programs Page 4 of 5 may be contracted to other private providers to the extent that finances permit
and local circumstances dictate. (b) Each public health department shall have the ability to provide counseling and testing for the human immunodeficiency virus to each patient who receives
services and shall offer the testing on a voluntary basis to each patient who
requests the test. (c) Each public health department shall provide a program of counseling and testing for human immunodeficiency virus infection, on an anonymous or
confidential basis, dependent on the patient's desire. If the testing is performed
on an anonymous basis, only the statistical information relating to a positive
test for human immunodeficiency virus infection shall be reported to the
cabinet. If the testing is performed on a confidential basis, the name and other
information specified in KRS 214.645 shall be reported to the cabinet. The
cabinet shall continue to provide for anonymous testing and counseling. (d) The result of a serologic test conducted under the auspices of the cabinet shall not be used to determine if a person may be insured for disability, health, or
life insurance or to screen or determine suitability for, or to discharge a person
from, employment. Any person who violates the provisions of this subsection
shall be guilty of a Class A misdemeanor. (7) No public health department and no other person in this state shall conduct or hold themselves out to the public as conducting a testing program for acquired
immunodeficiency syndrome, acquired immunodeficiency syndrome related
complex, or human immunodeficiency virus status without first registering with the
cabinet, complying with all other applicable provisions of state law, and meeting the
following requirements:
(a) The program shall be directed by a person who has completed an educational course approved by the cabinet in the counseling of persons with acquired
immunodeficiency syndrome, acquired immunodeficiency syndrome related
complex, or human immunodeficiency virus infection; (b) The program shall have all medical care supervised by a physician licensed under the provisions of KRS Chapter 311; (c) The program shall have all laboratory procedures performed in a laboratory licensed under the provisions of KRS Chapter 333; (d) Informed consent shall be required prior to testing. Informed consent shall be preceded by an explanation of the test, including its purpose, potential uses,
and limitations and the meaning of its results; (e) The program, unless it is a blood donor center, shall provide pretest counseling on the meaning of a test for human immunodeficiency virus,
including medical indications for the test; the possibility of false positive or
false negative results; the potential need for confirmatory testing; the potential
social, medical, and economic consequences of a positive test result; and the
need to eliminate high-risk behavior; Page 5 of 5 (f) The program shall provide supplemental corroborative testing on all positive test results before the results of any positive test is provided to the patient; (g) The program shall provide post-test counseling, in person, on the meaning of the test results; the possible need for additional testing; the social, medical,
and economic consequences of a positive test result; and the need to eliminate
behavior which might spread the disease to others; (h) Each person providing post-test counseling to a patient with a positive test result shall receive specialized training, to be specified by regulation of the
cabinet, about the special needs of persons with positive results, including
recognition of possible suicidal behavior, and shall refer the patient for further
health and social services as appropriate; (i) When services are provided for a charge during pretest counseling, testing, supplemental testing, and post-test counseling, the program shall provide a
complete list of all charges to the patient and the cabinet; and (j) Nothing in this subsection shall be construed to require a facility licensed under KRS Chapter 333 or a person licensed under the provisions of KRS
Chapters 311, 312, or 313 to register with the cabinet if he or she does not
advertise or hold himself or herself out to the public as conducting testing
programs for human immunodeficiency virus infection or specializing in such
testing. (8) Any violation of this section by a licensed health-care provider shall be a ground for disciplinary action contained in the professional's respective licensing chapter. (9) Except as provided in subsection (6)(d) of this section and KRS 304.12-013, insurers and others participating in activities related to the insurance application and
underwriting process shall be exempt from this section. (10) The cabinet shall develop program standards consistent with the provisions of this section for counseling and testing persons for the human immunodeficiency virus. Effective: July 15, 2010
History: Amended 2010 Ky. Acts ch. 85, sec. 74, effective July 15, 2010. -- Amended 2005 Ky. Acts ch. 99, sec. 467, effective June 20, 2005. -- Amended 2004 Ky. Acts
ch. 102, sec. 3, effective July 13, 2004. -- Amended 2000 Ky. Acts ch. 432, sec. 8,
effective July 14, 2000. -- Amended 1998 Ky. Acts ch. 426, sec. 414, effective July
15, 1998. -- Amended 1994 Ky. Acts ch. 309, sec. 2, effective July 15, 1994. --
Created 1990 Ky. Acts ch. 443, sec. 40, effective July 13, 1990.